|
|
||||||||
Department of Nutritional Sciences (D.J.A.J., V.V., C.W.C.K., C.C.M., E.V., L.S.A.A., E.W.), Faculty of Medicine, University of Toronto and the Clinical Nutrition and Risk Factor Modification Center, St Michaels Hospital, Toronto, Ontario
Nestle Research Center (P.W.), Lausanne, Switzerland
National Starch and Chemical Company (R.J., S.W.), Bridgewater, New Jersey
Address reprint requests to: David JA Jenkins, MD, PhD, FACN, St. Michaels Hospital, 61 Queen Street East, 6th Floor, Toronto, Ontario, CANADA M5C 2T2
Objective: To assess the effects on fecal bulking, fecal short chain fatty acid (SCFA) production, blood lipids and glycemic indices of two different forms of resistant starch (RS2 and RS3) from a high-amylose cornstarch.
Methods: Twenty-four healthy subjects (12 men; 12 women) consumed four supplements taken for 2 weeks in random order separated by 2-week washout periods. The supplements were a low-fiber (control) and supplements providing an additional 30 g dietary fiber as wheat bran (high-fiber control) or the equivalent amount of resistant starch analyzed gravimetrically as dietary fiber from RS2 or RS3. Four-day fecal collections and 12-hour breath gas collections were obtained at the end of each period. Fasting blood was taken at the beginning and end of each period. Glycemic indices of supplements were also assessed.
Results: The wheat bran supplement increased fecal bulk 96±14 g/day compared with the low-fiber control (p<0.001) with the mean for both resistant starches also being greater (22±8 g/day) than the low-fiber control (p=0.013). On the resistant starch phases, the mean fecal butyrate:SCFA ratio, which has been suggested to have positive implications for colonic health, was significantly above the low-fiber control by 31±14% (p=0.035). Resistant starches did not alter serum lipids, urea or breath H2 or CH4. No significant differences in glycemic index were seen between the RS and control supplements.
Conclusion: The potential physiological benefits of the resistant starches studied appear to relate to colonic health in terms of effects on fecal bulk and SCFA metabolism.
Key words: resistant starch, fecal bulk, blood lipids, glycemic index, colon, short chain fatty acids
This article has been cited by other articles:
![]() |
J. M. W. Wong and D. J. A. Jenkins Carbohydrate Digestibility and Metabolic Effects J. Nutr., November 1, 2007; 137(11): 2539S - 2546S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Ramsay, K. P. Scott, J. C. Martin, M. T. Rincon, and H. J. Flint Cell-associated {alpha}-amylases of butyrate-producing Firmicute bacteria from the human colon. Microbiology, November 1, 2006; 152(Pt 11): 3281 - 3290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D. Robertson, A. S Bickerton, A L. Dennis, H. Vidal, and K. N Frayn Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism Am. J. Clinical Nutrition, September 1, 2005; 82(3): 559 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Han, M. Sekikawa, K.-I. Shimada, K. Sasaki, K. Ohba, and M. Fukushima Resistant Starch Fraction Prepared from Kintoki Bean Affects Gene Expression of Genes Associated with Cholesterol Metabolism in Rats Experimental Biology and Medicine, September 1, 2004; 229(8): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M Davy, K. P Davy, R. C Ho, S. D Beske, L. R Davrath, and C. L Melby High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men Am. J. Clinical Nutrition, August 1, 2002; 76(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Behall, J. C. Howe, and R. A. Anderson Apparent Mineral Retention Is Similar in Control and Hyperinsulinemic Men after Consumption of High Amylose Cornstarch J. Nutr., July 1, 2002; 132(7): 1886 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF] |
||||
![]() |
D. L. Topping and P. M. Clifton Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides Physiol Rev, July 1, 2001; 81(3): 1031 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Lopez, M.-A. Levrat-Verny, C. Coudray, C. Besson, V. Krespine, A. Messager, C. Demigné, and C. Rémésy Class 2 Resistant Starches Lower Plasma and Liver Lipids and Improve Mineral Retention in Rats J. Nutr., April 1, 2001; 131(4): 1283 - 1289. [Abstract] [Full Text] |
||||
![]() |
S. W Rizkalla, J. Luo, M. Kabir, A. Chevalier, N. Pacher, and G. Slama Chronic consumption of fresh but not heated yogurt improves breath-hydrogen status and short-chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1474 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. A. Jenkins, C. W. C. Kendall, V. Vuksan, E. Vidgen, E. Wong, L. S. A. Augustin, and V. Fulgoni III Effect of Cocoa Bran on Low-Density Lipoprotein Oxidation and Fecal Bulking Arch Intern Med, August 14, 2000; 160(15): 2374 - 2379. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |